Cagrilintide

Cagrilintide (AM833) is a long-acting acylated analogue of amylin, a hormone co-secreted with insulin by pancreatic beta cells. In preclinical research it is studied for engagement of amylin and calcitonin receptors, satiety and energy-intake signalling, and body-weight regulation pathways in metabolic models. Its fatty-acid acylation extends its half-life compared with native amylin, making it a long-acting research probe. Supplied at >99% HPLC purity for in-vitro research use only.

A significant area of metabolic research examines amylin-pathway compounds in combination with GLP-1 receptor agonists, because the two engage distinct but complementary energy-balance pathways. In research settings each compound is reconstituted separately and combined at the point of use according to the experimental protocol. Researchers should consult the published literature for appropriate concentration ratios. Cagrilintide and GLP-1 agonists are distinct research tools and are not interchangeable. Not for human consumption — for research use only.

No. Cagrilintide is an investigational research compound and is not a registered pharmaceutical product in Australia — it is not stocked at retail pharmacies such as Chemist Warehouse and has not been approved for human use by the TGA. Peptide Warehouse Australia supplies Cagrilintide exclusively as a lyophilised powder for in-vitro laboratory research purposes. Not for human consumption — for research use only.

Add bacteriostatic water to the vial slowly, directing it down the inside wall rather than onto the powder, then swirl gently until fully dissolved. Do not shake or vortex. Storage: Lyophilised — store at −20°C for up to 24 months. Reconstituted — refrigerate at 2–8°C and use within 4 weeks, protected from light. BAC water is available at /products/bac-water-10ml. Not for human consumption — for research use only.

Legal status: Cagrilintide is legal to purchase in Australia for legitimate laboratory research purposes. It is not for human consumption, therapeutic, cosmetic, or veterinary use and is not TGA-approved. Purchasers must be 18+ and confirm research-only intent. Quality: each batch is manufactured to a >99% HPLC purity specification under GMP-certified conditions.

Peptide Warehouse Australia stocks Cagrilintide 5mg and ships nationwide via Australia Post with full tracking. Orders placed before 12PM AEST dispatch the same business day from our Melbourne warehouse; orders after 12PM AEST dispatch the next business day. Standard Post $8.99 (2–6 business days); Express Post $13.99 (1–3 business days); free shipping on all orders over $199 AUD. All orders ship in discreet plain packaging with no external branding. Not for human consumption — for research use only.

Cagrilintide is a long-acting analogue of amylin, a hormone co-secreted with insulin, and is studied for engagement of amylin and calcitonin receptors involved in satiety and energy-balance signalling in research models. Its acylation extends its half-life relative to native amylin. Not for human consumption — for research use only.

An active area of metabolic research pairs Cagrilintide with the GLP-1 agonist semaglutide (a combination referred to in research as CagriSema) to study complementary amylin and incretin pathways. This combination research is a prominent reason Cagrilintide is studied. Not for human consumption — for research use only.

Cagrilintide acts on amylin/calcitonin receptors, a pathway distinct from the incretin (GLP-1/GIP) receptors targeted by compounds like semaglutide or tirzepatide. This is why it is studied as a complementary, not interchangeable, metabolic research tool. Not for human consumption — for research use only.

Cagrilintide is acylated to extend its duration of action substantially relative to native amylin, supporting long-acting research applications. Working concentrations and intervals depend on the protocol and should be drawn from the literature. Not for human consumption — for research use only.

Cagrilintide is often shortened to Cagri and appears under the development code AM833. It is a long-acting amylin-analogue research peptide. For in-vitro research use only.